SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe is facing significant volatility following a surprise announcement that CEO Shantanu Narayen will step down, overshadowing the company's strong Q1 financial results. The market is actively debating whether this leadership transition, combined with intense competition in the AI software space, marks the end of Adobe's dominant growth era or an overdue opportunity for a strategic AI-driven turnaround.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund (USO) is experiencing massive volatility and record-breaking trading volume as investors react to escalating Middle East tensions, specifically renewed missile attacks on tankers and threats to the Strait of Hormuz. Community discourse is sharply divided between those betting on a sustained supply-shock rally toward higher price levels and others warning of a potential rug-pull as geopolitical fear premiums collide with government supply-side interventions.

Trump For President

Investors are intensely debating the future of $TRUMP as the token faces significant volatility and community division amid broader scrutiny of related political and business ventures. While some proponents emphasize its status as a symbolic asset, critics point to mounting pressure from regulatory discussions, internal controversies, and a steady downward price trend that has sparked widespread concern among retail holders.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is currently drawing intense investor attention as reports of the company converting its xAI investment into a SpaceX stake trigger discussions about deepening ties between Elon Musk's ventures. Meanwhile, community sentiment remains sharply polarized, with traders actively debating the stock's valuation amidst broader macro pressures like oil price volatility and the ongoing impact of the Middle East conflict on the clean energy sector.

What Is Pi Network? Pi Network is a social cryptocurrency, developer platform, and ecosystem designed for widespread accessibility and real-world utility. It enables users to mine and transact Pi using a mobile-friendly interface while supporting applications built within its blockchain ecosystem.  Supply Model and Mining Mechanism The Maximum Supply of Pi is 100 billion tokens. The Maximum Supply is comprised of the following: 65 Billion tokens (or 65%) are allocated for all community mining rewards; 10 billion (10%) are allocated for foundation reserves; 5 billion (5%) are allocated for liquidity purposes; and 20 billion (20%) are allocated for the Core Team. Each allocation mentioned above tracks the community Migrated Mining Rewards issuance pace, so the proportions of each allocation in the total supply remains the same at any given time.   The Effective Total Supply of Pi—the total Pi supply at the current time—allocates Pi proportionally the same as the Maximum Supply. Since every allocation tracks the Migrated Mining Rewards of the community, the Effective Total Supply can be calculated by dividing the current Migrated Mining Rewards of Pi on the Mainnet blockchain by 65%. The other allocations within the Effective Total Supply can then be calculated based on the same proportions as the Maximum Supply, e.g. at most 10% of the Effective Total Supply is available in the foundation reserve, 5% of the Effective Total Supply is available for liquidity purposes, and 20% of the Effective Total Supply is available for the Core Team. This remains true despite the fact that all tokens were minted at the genesis as technically required by the blockchain protocol.  Circulating Supply includes all Migrated Mining Rewards and all tokens that entered circulation from other buckets of the allocations, which at its maximum could be summed up to equal the Effective Total Supply.   Pi’s mining rewards are distributed based on an issuance formula that follows a declining exponential model defined in the Pi whitepaper. Users can increase the amount of mining rewards they receive based on their individual contributions to the network, like Security Circles, using utility-based Pi apps, running Nodes, etc. For each month, the amount of Pi to be distributed as mobile balance is capped and determined by the model, regardless of how many people or how many types of mining rewards there are during the month. The capping is achieved by the design of a system-wide base mining rate, and each type of mining rewards to each individual are just a multiplier of this base mining rate. As the monthly supplies always diminish, the base mining rate generally decreases over time.   Fewer Pi may also be issued because the real Pi issuance on the blockchain depends on Pioneers passing KYC and completing all steps required for migration to the Mainnet. Despite all efforts to facilitate and remind Pioneers to complete those required steps, there are always dropoffs along the way, resulting in less than all outstanding mobile balances to be issued on the blockchain. Because of this mechanism, the community issued amount (Migrated Mining Rewards) on the blockchain will likely be closer and closer to a line lower than the 65 billion. This is thus the reason for the variable Effective Total Supply which incorporates this effect. Effective Total Supply results from all Migrated Mining Rewards divided by 65%, as opposed to the Maximum Supply of 100 billion.  Ecosystem and Adoption Pi Network has built an integrated ecosystem that facilitates real-world transactions and decentralized applications. Pi can be used as a medium of exchange for goods and services, including online commerce and local brick-and-mortar businesses.  Users can engage with Core Team and community-built apps in the Pi ecosystem through the Pi Browser, where integrated features like the Pi Wallet provide a seamless experience. Events like PiFest 2024 showcased Pi’s growing adoption, with over 27,000 active sellers and 28,000 test merchants across 160 countries.  Who Are the Founders of Pi Network? Pi Network was founded by Dr. Nicolas Kokkalis and Dr. Chengdiao Fan, both of whom have PhDs from Stanford University and a passion for improving human lives through technology.  Dr. Nicolas Kokkalis is a Stanford PhD in EE and postdoc in CS with research on distributed systems and human-computer interaction. His work focuses on combining distributed systems and human computer interaction to bring cryptocurrency to everyday people. As a strong and long-term believer of the technical, financial and social potential of cryptocurrencies, he is determined to move them beyond their current limitations and is committed to bringing the power of blockchain to more people.  Dr. Chengdiao Fan holds a Stanford PhD in Anthropological Sciences, harnessing social computing to unlock human potential on a global scale. Chengdiao is building Pi Network to mobilize individuals all over the world to participate and be rewarded for their contributions, and establish an inclusive ecosystem for global citizens to unleash and capture their own agency, and in turn create utilities and productions for society and the world.  Compliance and Identity Verification Pi Network follows a one-account-per-person policy through its Know Your Customer (KYC) solution. This system combines machine automation and human verification to authenticate user identities while preserving privacy.  The KYC process emphasizes real individuals, combats fraudulent activities and enables fair participation in the mining process of the network. Pi’s identity verification approach balances scalability, security, and accessibility, allowing millions of users worldwide to validate their accounts while maintaining regulatory compliance.

Pi Network

Pi Network is drawing significant attention as community members track potential exchange listings and navigate the ongoing mainnet migration process. While some users remain optimistic about long-term adoption and utility, others are actively debating concerns regarding KYC verification, locked balances, and the project's roadmap.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is trading under intense pressure as escalating geopolitical tensions in the Middle East and spiking oil prices trigger widespread risk-off sentiment. The market community is actively debating the durability of the recent sell-off, with many traders questioning the absence of typical 'dip buying' support while bracing for further volatility ahead of key economic data.

PayPay

PayPay is drawing significant market attention following its major U.S. stock market debut, with investors debating whether the fintech's strong penetration in the Japanese digital payments space justifies current volatility. Discussion across the community remains divided as traders evaluate the firm's competitive valuation and the influence of institutional interest on its initial trading performance.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is experiencing heightened volatility and erratic overnight price action as traders debate the long-term economic impact of the escalating conflict in the Middle East versus short-term intervention measures. The community remains deeply divided, with intense discussions focused on the potential effectiveness of energy policy shifts, the sustainability of recent market rallies, and concerns over broader inflation risks.

ProShares Trust - ProShares UltraShort Bloomberg Crude Oil -2x Shares

ProShares UltraShort Bloomberg Crude Oil

ProShares UltraShort Bloomberg Crude Oil (SCO) is trending as retail investors express intense frustration over significant decay in the fund's value and its tendency to decouple from spot crude oil price movements. The community is actively debating the volatility of inverse ETFs, with many traders using SCO as a high-risk tool to scalp or hedge against geopolitical tensions and crude oil price fluctuations.

Rubrik, Inc. engages in the provision of cloud data management solutions. Its solutions include backup and recovery, VM backup, Microsoft 365, ransom ware recovery, database backup, cloud solutions, and Polaris sonar. Rubrik products include data protection, data threat analytics, data security posture and cyber recovery. The company was founded by Bipul Sinha, Arvind Jain, Soham Mazumdar, and Arvind Nithrakashyap in December 2013 and is headquartered in Palo Alto, CA.

Rubrik Inc. - Ordinary Shares - Class A

Rubrik Inc. - Class A

Rubrik is facing significant selling pressure as investors weigh strong fundamental performance and earnings beats against broader concerns about high valuations and potential disruption from AI-driven tools. Community sentiment is deeply divided, with some investors aggressively accumulating on what they view as a temporary pullback while others remain bearish due to consistent price declines and ongoing concerns about stock-based compensation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

FY2030 Earnings Forecast for Savara Issued By HC Wainwright

Savara Inc. (NASDAQ:SVRA - Free Report) - HC Wainwright issued their FY2030 earnings per share estimates for shares of Savara in a report released on Monday, March 9th. HC Wainwright analyst A. Fein...

Savara Provides Regulatory Update on the MOLBREEVI* Development Program in Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP)

Savara Inc. (the Company) (Nasdaq: SVRA), a clinical-stage biopharmaceutical company focused on rare respiratory diseases, today announced that it has received the Day 74 Letter from the FDA which...

Savara Announces Participation in 2026 Citizens Life Sciences Conference

Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that members of the management team will participate in a...

Savara Inc. (NASDAQ:SVRA) Receives Average Recommendation of "Moderate Buy" from Analysts

Savara Inc. (NASDAQ:SVRA - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the nine research firms that are presently covering the company, Marketbeat reports...

Savara Highlights FDA Priority Review for Molbreevi as Aug. 22 PDUFA Date Nears

Savara (NASDAQ:SVRA) executives highlighted recent regulatory and commercial milestones for its lead program, molgramostim inhalation solution (Molbreevi), during a discussion at Oppenheimer's 36th...

<ul class="summary-bullets"><li>The FDA is expected to decide on the company’s application by Aug. 22, 2026.&nbsp;</li><li>Molbreevi had previously been granted FDA’s fast track, breakthrough therapy and orphan drug designations.&nbsp;</li><li>The company also plans to submit applications to Europe’s EMA and the UK’s MHRA seeking approval for Molbreevi by the end of the first quarter of 2026.</li></ul> Shares of Savara Inc. (SVRA) rallied over 3% after hours on Friday after the company announced that it has submitted an application to the U.S. Food and Drug Administration seeking approval for its experimental therapy Molbreevi.The company is <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.businesswire.com/news/home/20260220017435/en/Savara-Announces-the-U.S.-Food-and-Drug-Administration-FDA-Filed-the-MOLBREEVI-Biologics-License-Application-BLA-in-Autoimmune-Pulmonary-Alveolar-Proteinosis-Autoimmune-PAP">seeking</a> approval for Molbreevi to treat patients with Autoimmune Pulmonary Alveolar Proteinosis (autoimmune PAP). The agency has granted the therapy priority review and is expected to decide on the application by Aug. 22, 2026.Molbreevi had previously been granted FDA’s fast track, breakthrough therapy and orphan drug designations.<h2 class="st-heading-2">About Autoimmune PAP</h2>Autoimmune PAP is a rare lung disease characterized by the abnormal build-up of surfactant, consisting of proteins and lipids, in the lung’s alveoli. While in a healthy lung surfactant is cleared, in autoimmune PAP it is left to accumulate causing impaired gas transfer, resulting in clinical symptoms of shortness of breath, often with cough and frequent fatigue.The company now plans to submit applications to the European Medicines Agency (EMA) and the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) seeking approval for Molbreevi by the end of the first quarter of 2026.“We believe the considerable body of data in the application demonstrates MOLBREEVI improves pulmonary gas transfer, quality of life, and the clinical symptoms associated with this rare and debilitating lung disease.” said CEO Matt Pauls.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around SVRA rose from ‘neutral’ to ‘bullish’ territory over the past 24 hours, while message volume remained at ‘high’ levels.<a href="https://stocktwits.com/symbol/SVRA">SVRA stock</a> has more than doubled over the past 12 months.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/sarepta-hits-fresh-hurdle-as-court-revives-patent-lawsuit-with-regenxbio-over-muscular-disorder-therapy/cZRNSgQR4xu">Sarepta Hits Fresh Hurdle As Court Revives Patent Lawsuit With Regenxbio Over Muscular Disorder Therapy</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Global stock market chart and trading board - stock photo

SVRA Stock Rises After Hours As FDA Grants Priority Review For Lung Disorder Therapy

The company is seeking approval for Molbreevi to treat patients with Autoimmune Pulmonary Alveolar Proteinosis (autoimmune PAP).

Equity

The company is seeking approval for Molbreevi to treat patients with Autoimmune Pulmonary Alveolar Proteinosis (autoimmune PAP).


Savara Announces the U.S. Food and Drug Administration (FDA) Filed the MOLBREEVI* Biologics License Application (BLA) in Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP)

Savara Inc. (Nasdaq: SVRA) (the Company), a clinical-stage biopharmaceutical company focused on rare respiratory diseases, announced the FDA has filed for review the BLA for MOLBREEVI as a therapy to...

GSA Capital Partners LLP Has $1.33 Million Stock Holdings in Savara Inc. $SVRA

GSA Capital Partners LLP trimmed its holdings in Savara Inc. (NASDAQ:SVRA - Free Report) by 47.4% during the third quarter, according to its most recent 13F filing with the Securities and Exchange...

Savara Eyes August PDUFA for MOLBREEVI as FDA BLA Filing Decision Nears, Execs Say at Summit

Savara (NASDAQ:SVRA) executives provided an update on the company's regulatory timeline, manufacturing changes, clinical evidence, and commercial preparations for MOLBREEVI during a presentation at...

Savara Announces New Employment Inducement Grant

Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to a new employee. On February 10, 2026...

Savara, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Its program includes molgramostim, which is an inhaled formulation of recombinant human GM-CSF and being developed for the treatment of autoimmune pulmonary alveolar proteinosis. The company was founded in December 1995 and is headquartered in Langhorne, PA.

SVRA
Savara Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SVRA News

SVRASavara Inc